TY - JOUR
T1 - Low circulating concentrations of very long chain saturated fatty acids are associated with high risk of mortality in kidney transplant recipients
AU - Vogelpohl, Fabian A.
AU - Gomes-Neto, António W.
AU - Martini, Ingrid A.
AU - Sotomayor, Camilo G.
AU - Groothof, Dion
AU - Osté, Maryse C.J.
AU - Heiner-Fokkema, Rebecca M.
AU - Muskiet, Frits A.J.
AU - Berger, Stefan P.
AU - Navis, Gerjan
AU - Kema, Ido P.
AU - Bakker, Stephan J.L.
N1 - Funding Information:
Generation of the Transplant Lines Food and Nutrition Biobank and Cohort Study (clinical trial reg. no. NCT02811835, Clinical-Trials.gov) was funded by the Top Institute Food and Nutrition (grant A-1003).S.J.L.B. is principal investigator of the Transplant Lines Biobank and Data Repository of the University Medical Center Groningen. F.A.V. received support by the Van Walree Grant of the Royal Netherlands Academy of Arts and Sciences.
Funding Information:
Acknowledgments: S.J.L.B. is principal investigator of the Transplant Lines Biobank and Data Repository of the University Medical Center Groningen. F.A.V. received support by the Van Walree Grant of the Royal Netherlands Academy of Arts and Sciences.
Funding Information:
Funding: Generation of the Transplant Lines Food and Nutrition Biobank and Cohort Study (clinical trial reg. no. NCT02811835, Clinical-Trials.gov) was funded by the Top Institute Food and Nutrition (grant A-1003).
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/10
Y1 - 2021/10
N2 - Kidney transplant recipients (KTR) are at increased risk of mortality, particularly from infectious diseases, due to lifelong immunosuppression. Although very long chain saturated fatty acids (VLSFA) have been identified as crucial for phagocytosis and clearance of infections, their association with mortality in immunocompromised patient groups has not been studied. In this prospective cohort study we included 680 outpatient KTR with a functional graft ≥1 year and 193 healthy controls. Plasma VLSFA (arachidonic acid (C20:0), behenic acid (C22:0) and lignoceric acid (C24:0)) were measured by gas chromatography coupled with a flame ionization detector. Cox regression analyses was used to prospectively study the associations of VLSFA with all-cause and cause-specific mortality. All studied VLSFA were significantly lower in KTR compared to healthy controls (all p < 0.001). During a median (interquartile range) follow-up of 5.6 (5.2–6.3) years, 146 (21%) KTR died, of which 41 (28%) died due to infectious diseases. In KTR, C22:0 was inversely associated with risk of all-cause mortality, with a HR (95% CI) per 1-SD-increment of 0.79 (0.64–0.99), independent of adjustment for potential confounders. All studied VLSFA were particularly strongly associated with mortality from infectious causes, with respective HRs for C20:0, C22:0 and C24:0 of 0.53 (0.35–0.82), 0.48 (0.30–0.75), and 0.51 (0.33–0.80), independent of potential confounders. VLSFA are inversely associated with infectious disease mortality in KTR after adjustment, including HDL-cholesterol. Further studies are needed to assess the effect of VLSFA-containing foods on the risk of infectious diseases in immunocompromised patient groups.
AB - Kidney transplant recipients (KTR) are at increased risk of mortality, particularly from infectious diseases, due to lifelong immunosuppression. Although very long chain saturated fatty acids (VLSFA) have been identified as crucial for phagocytosis and clearance of infections, their association with mortality in immunocompromised patient groups has not been studied. In this prospective cohort study we included 680 outpatient KTR with a functional graft ≥1 year and 193 healthy controls. Plasma VLSFA (arachidonic acid (C20:0), behenic acid (C22:0) and lignoceric acid (C24:0)) were measured by gas chromatography coupled with a flame ionization detector. Cox regression analyses was used to prospectively study the associations of VLSFA with all-cause and cause-specific mortality. All studied VLSFA were significantly lower in KTR compared to healthy controls (all p < 0.001). During a median (interquartile range) follow-up of 5.6 (5.2–6.3) years, 146 (21%) KTR died, of which 41 (28%) died due to infectious diseases. In KTR, C22:0 was inversely associated with risk of all-cause mortality, with a HR (95% CI) per 1-SD-increment of 0.79 (0.64–0.99), independent of adjustment for potential confounders. All studied VLSFA were particularly strongly associated with mortality from infectious causes, with respective HRs for C20:0, C22:0 and C24:0 of 0.53 (0.35–0.82), 0.48 (0.30–0.75), and 0.51 (0.33–0.80), independent of potential confounders. VLSFA are inversely associated with infectious disease mortality in KTR after adjustment, including HDL-cholesterol. Further studies are needed to assess the effect of VLSFA-containing foods on the risk of infectious diseases in immunocompromised patient groups.
KW - Arachidic acid
KW - Behenic acid
KW - Epidemiology
KW - Gas chromatography
KW - Infection
KW - Kidney transplantation
KW - Lignoceric acid
KW - Sphingolipids
KW - Very long chain saturated fatty acids
U2 - 10.3390/nu13103383
DO - 10.3390/nu13103383
M3 - Article
C2 - 34684385
AN - SCOPUS:85115642126
VL - 13
JO - Nutrients
JF - Nutrients
SN - 2072-6643
IS - 10
M1 - 3383
ER -